Medical

Quentin O'Brien

​​This POV highlights Bluesky as a new frontier for medical affairs, enabling scientific exchange, KOL/DOL engagement, and data amplification through unique features.

Brad Aufderheide

Test your rare disease marketing knowledge. Discover myths, facts, and best practices for engaging patients early, addressing unmet needs, and effectively amplifying their voices.

Brad Aufderheide

Oncology is looking more and more like a rare disease in its treatment, with a shift towards hyper-personalized care and deploying digital tools that empower patients, advocates, a...

Brad Aufderheide

Discover the true impact of rare disease and the urgent need for innovation through data that challenges misconceptions and highlights unmet needs.

Brad Aufderheide

Review our recommendations for a unique approach to rare disease marketing to recognize the distinct challenges and nuances that set it apart from traditional healthcare marketing ...

Quentin O'Brien

AI is transforming medical affairs and driving engagement. To stay ahead, teams must embrace AI, upskill, and adapt. Read the full article for post-conference insights from the 202...

Jasmine Singh

Explore the Klick Mediverse, where medical, scientific, and regulatory expertise converge to transform healthcare commercialization.

Stakeholder Engagement Team

Klick’s Stakeholder Maturity Index (SMI) framework provides a structured approach to stakeholder engagement strategies.

Stakeholder Engagement Team

Patients, care partners, advocacy groups, and even government agencies can be part of a holistic stakeholder engagement strategy. Does your ecosystem go beyond the expected?

Stakeholder Engagement Team

The Stakeholder Maturity Index (SMI) is a strategic tool designed to enhance stakeholder engagement by assessing four key areas.

Stakeholder Engagement Team

The Stakeholder Maturity Index (SMI) Workbook is a comprehensive guide that helps organizations elevate their stakeholder engagement strategies.

Stakeholder Engagement Team

The Stakeholder Maturity Index (SMI) evaluates your organization’s KOL-engagement strategy and provides personalized insights to enhance stakeholder relationships.

Brad Aufderheide

The oncology landscape is undergoing a revolution, driven by cutting-edge innovations in personalized medicine, AI-powered decision-making, and more.

Nicole Watts, Sean Lim

In today’s pharmaceutical landscape, trust is crucial. FDA research shows that HCPs are more likely to prescribe when pharma promotional materials emphasize transparency.

Tim Mitchell

Looking for actionable strategies to harness the influence of digital opinion leaders in healthcare?

Randi Goeckeler , Robert Groebel III

This article discusses how stakeholder engagement teams have shifted from more transactional functions to orchestrators of strategic partnerships.

Dane Lund, Marina Oraczewski, Jorge Durand

Part 2 of our 2024 ASCO key takeaways highlights major advancements in AI integration within oncology. Key themes included AI’s role in addressing established oncology challenges, ...

Tim Mitchell, Mike Melnick

Despite high aspirations, many medical affairs organizations struggle with omnichannel engagement due to knowledge gaps, commercial biases, and resistance to change. Klick’s MedXD™...

Value Access Reimbursement Team

Patient Support Programs (PSPs) are evolving to provide more personalized and data-driven assistance, significantly enhancing patient outcomes. These programs now feature seamless ...

Dane Lund, Marina Oraczewski, Jorge Durand

The 2024 ASCO Annual Meeting showcased significant advancements, emphasizing patient-centric innovation and integration of palliative care. Highlights included progress in immunoth...

Randi Goeckeler

Facing the challenge of effectively engaging with Key Opinion Leaders (KOLs) for long-term success, brands constantly quest to refine their strategies beyond mere transactions. Kli...

Tim Mitchell

This article sheds light on the evolving dynamics of social media within medical affairs, detailing the transition from passive observation to proactive engagement. Central to the ...

Bahar Ameri, Jessica Tsalikis, Jagpreet Kaur Maker, Kevin Pickering

This POV provides background context, details on the contents of the final guidance, and Klick’s recommendations for DTC TV and radio ads at any stage of the project lifecycle. On...

Cassandra Carroll

Navigating FDA regulations in pharmaceutical marketing is a nuanced journey that requires a delicate balance between impactful promotion and adherence to guidelines. In a new serie...

Jodie Grubb, MB Caschetta

Today, most PSPs are well equipped to address logistical barriers such as copay support and prior authorization assistance. Over time, they have evolved to include other aspects of...